Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 8:00 AM ET


Company Overview of Dr. Falk Pharma GmbH

Company Overview

Dr. Falk Pharma GmbH develops and sells medications for indications in hepatology and gastroenterology. The company offers medications for inflammatory bowel diseases, diverticular diseases, constipation/irritable bowel syndrome, disorders of lipid metabolism, and liver diseases. It sells its prescription drugs through local partners and subsidiary companies worldwide. Dr. Falk Pharma GmbH was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. The company was founded in 1960 and is based in Freiburg, Germany.

Leinenweberstr. 5

Postbox 6529

Freiburg,  79041


Founded in 1960


49 761 1514 0


49 761 1514 321

Key Executives for Dr. Falk Pharma GmbH

Managing Director, Member of Executive Board, President of The Falk Foundation E.V. and Director of Falk Foundation e. V.
Compensation as of Fiscal Year 2015.

Dr. Falk Pharma GmbH Key Developments

Medigene AG Enters into Licensing Agreement with Dr Falk Pharma GmbH

Medigene AG has entered into an exclusive global licensing agreement with Dr. Falk Pharma GmbH for the development and commercialization of its drug candidate RhuDex for indications in hepatology and gastroenterology. Falk Pharma will assume responsibility and all costs relating to the clinical development and marketing of RhuDex in these therapeutic areas. Medigene will receive an upfront payment and future milestone payments from Falk Pharma, plus double-digit RhuDex royalties.

Similar Private Companies By Industry

Company Name Region
Wockhardt Germany GmbH Europe
Fournier Pharma GmbH Europe
Biotie Therapies GmbH Europe
Lipoid GmbH Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dr. Falk Pharma GmbH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at